The Board of Directors of Chemed Corporation recently announced two significant capital allocation decisions: authorizing an additional stock repurchase program of up to $300 million, while maintaining the quarterly cash dividend at $0.60 per share.

This move highlights the company's ongoing commitment to shareholder returns and reflects management's confidence in future cash flow generation. The expansion of the stock repurchase program will provide the company with greater flexibility to optimize its capital structure by timely repurchasing outstanding shares. Meanwhile, a stable dividend policy continues to offer investors predictable cash flow returns. The combination of these two decisions not only demonstrates the company's robust financial strength, but also conveys a positive outlook for its long-term growth prospects.